Welcome to Stratatech Corporation

Stratatech Corporation is a regenerative medicine company focused on the development of cell-based, tissue-engineered products for wound care. The keystone of Stratatech's approach is a proprietary human skin cell line that when properly cultured forms a fully stratified multi-layered human tissue with the physical strength and biological characteristics of intact human skin. This biologically active tissue is suitable for transplantation on patients using traditional surgical suturing techniques and should actively promote wound healing by the patient’s own cells. Stratatech is developing new products that have been genetically enhanced to over-express natural, human wound-healing factors that reduce infection, improve blood flow to the wound, and increase the rate of healing with reduced scarring. Our initial product development focus is on wound care products for soft tissue wounds, diabetic ulcers, and pressure ulcers. The Company’s NIKS™ cell technology and expertise in skin biology also provide future product opportunities in the skin care cosmeceutical market as well as the cosmetic surgery market. Stratatech has assembled a team of experienced research, production, clinical, and regulatory personnel to facilitate the discovery, development, and commercialization of our products.